Showing results (141-150 of 2,461) with videos related to
Sort By:
Pageof 247
Medrxiv : the Preprint Server for Health Sciences|April 21, 2021
Evaluating Vaccine Efficacy Against SARS-CoV-2 InfectionDan-Yu Lin, Yu Gu, Donglin Zeng, et al.Statistical Methods in Medical Research|October 1, 2014
Finite-sample corrected generalized estimating equation of population average treatment effects in stepped wedge cluster randomized trialsJoAnna M Scott, Allan deCamp, Michal Juraska, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2020
Evaluating the Efficacy of Coronavirus Disease 2019 VaccinesDan-Yu Lin, Donglin Zeng, Devan V Mehrotra, et al.The Journal of Infectious Diseases|September 19, 2025
Immune Correlates and Vaccine Immunobridging: Statistical Innovations, Challenges, and OpportunitiesMarco Carone, Charles J Wolock, Antonio Olivas-Martinez, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2021
Evaluating Vaccine Efficacy Against Severe Acute Respiratory Syndrome Coronavirus 2 InfectionDan-Yu Lin, Yu Gu, Donglin Zeng, et al.Plos One|March 26, 2016
FCGR2C Polymorphisms Associated with HIV-1 Vaccine Protection Are Linked to Altered Gene Expression of Fc-γ Receptors in Human B CellsXinxia Peng, Shuying S Li, Peter B Gilbert, et al.Human Vaccines|April 3, 2008
Towards prediction of degenerate CTL epitope recognitionFusheng Li, Denise M McKenney, Uma Malhotra, et al.Cytometry. Part a : the Journal of the International Society for Analytical Cytology|July 11, 2008
Development of an automated analysis system for data from flow cytometric intracellular cytokine staining assays from clinical vaccine trialsNicholas Shulman, Matthew Bellew, George Snelling, et al.Vaccine|February 5, 2011
HIV fragment gag vaccine induces broader T cell response in miceYe Liu, Fusheng Li, Yong Liu, et al.Statistical Methods in Medical Research|January 10, 2019
Methods for comparing durability of immune responses between vaccine regimens in early-phase trialsTed Westling, Michal Juraska, Kelly E Seaton, et al.Pageof 247